世界のB型肝炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatitis B Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2782 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、B型肝炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎ワクチン、抗ウイルス薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・B型肝炎治療の市場動向 ・企業の競争状況、市場シェア ・B型肝炎治療の種類別市場規模（B型肝炎ワクチン、抗ウイルス薬） ・B型肝炎治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・B型肝炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・B型肝炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・B型肝炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・B型肝炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・B型肝炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Bristol-Myers Squibb、Novira Therapeutics、Johnson & Johnson、Abivax、F. Hoffmann- La Roche、Novartis、Merck） ・結論

Market Analysis and Insights: Global Hepatitis B Therapeutics Market
The global Hepatitis B Therapeutics market size is projected to reach US$ 3061.6 million by 2026, from US$ 2489 million in 2019, at a CAGR of 3.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B Therapeutics market.

Global Hepatitis B Therapeutics Scope and Market Size
Hepatitis B Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hepatitis B Vaccine
Anti-viral Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatitis B Vaccine
1.2.3 Anti-viral Drugs
1.3 Market by Application
1.3.1 Global Hepatitis B Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis B Therapeutics Market Perspective (2016-2027)
2.2 Hepatitis B Therapeutics Growth Trends by Regions
2.2.1 Hepatitis B Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B Therapeutics Industry Dynamic
2.3.1 Hepatitis B Therapeutics Market Trends
2.3.2 Hepatitis B Therapeutics Market Drivers
2.3.3 Hepatitis B Therapeutics Market Challenges
2.3.4 Hepatitis B Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Therapeutics Players by Revenue
3.1.1 Global Top Hepatitis B Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B Therapeutics Revenue
3.4 Global Hepatitis B Therapeutics Market Concentration Ratio
3.4.1 Global Hepatitis B Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutics Revenue in 2020
3.5 Hepatitis B Therapeutics Key Players Head office and Area Served
3.6 Key Players Hepatitis B Therapeutics Product Solution and Service
3.7 Date of Enter into Hepatitis B Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B Therapeutics Breakdown Data by Type
4.1 Global Hepatitis B Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B Therapeutics Forecasted Market Size by Type (2022-2027)

5 Hepatitis B Therapeutics Breakdown Data by Application
5.1 Global Hepatitis B Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis B Therapeutics Market Size (2016-2027)
6.2 North America Hepatitis B Therapeutics Market Size by Type
6.2.1 North America Hepatitis B Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B Therapeutics Market Size by Type (2016-2027)
6.3 North America Hepatitis B Therapeutics Market Size by Application
6.3.1 North America Hepatitis B Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B Therapeutics Market Size by Application (2016-2027)
6.4 North America Hepatitis B Therapeutics Market Size by Country
6.4.1 North America Hepatitis B Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hepatitis B Therapeutics Market Size (2016-2027)
7.2 Europe Hepatitis B Therapeutics Market Size by Type
7.2.1 Europe Hepatitis B Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B Therapeutics Market Size by Type (2016-2027)
7.3 Europe Hepatitis B Therapeutics Market Size by Application
7.3.1 Europe Hepatitis B Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B Therapeutics Market Size by Application (2016-2027)
7.4 Europe Hepatitis B Therapeutics Market Size by Country
7.4.1 Europe Hepatitis B Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Type
8.2.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Application
8.3.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B Therapeutics Market Size by Region
8.4.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis B Therapeutics Market Size (2016-2027)
9.2 Latin America Hepatitis B Therapeutics Market Size by Type
9.2.1 Latin America Hepatitis B Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B Therapeutics Market Size by Application
9.3.1 Latin America Hepatitis B Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B Therapeutics Market Size by Country
9.4.1 Latin America Hepatitis B Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Type
10.2.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Application
10.3.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B Therapeutics Market Size by Country
10.4.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Novira Therapeutics
11.3.1 Novira Therapeutics Company Details
11.3.2 Novira Therapeutics Business Overview
11.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction
11.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.3.5 Novira Therapeutics Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Abivax
11.5.1 Abivax Company Details
11.5.2 Abivax Business Overview
11.5.3 Abivax Hepatitis B Therapeutics Introduction
11.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.5.5 Abivax Recent Development
11.6 F. Hoffmann- La Roche
11.6.1 F. Hoffmann- La Roche Company Details
11.6.2 F. Hoffmann- La Roche Business Overview
11.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction
11.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.6.5 F. Hoffmann- La Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Hepatitis B Therapeutics Introduction
11.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Hepatitis B Therapeutics Introduction
11.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2016-2021)
11.8.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatitis B Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatitis B Vaccine
Table 3. Key Players of Anti-viral Drugs
Table 4. Global Hepatitis B Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hepatitis B Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis B Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hepatitis B Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Hepatitis B Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hepatitis B Therapeutics Market Share by Regions (2022-2027)
Table 10. Hepatitis B Therapeutics Market Trends
Table 11. Hepatitis B Therapeutics Market Drivers
Table 12. Hepatitis B Therapeutics Market Challenges
Table 13. Hepatitis B Therapeutics Market Restraints
Table 14. Global Hepatitis B Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hepatitis B Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2020)
Table 17. Ranking of Global Top Hepatitis B Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hepatitis B Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis B Therapeutics Product Solution and Service
Table 21. Date of Enter into Hepatitis B Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hepatitis B Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Hepatitis B Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hepatitis B Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hepatitis B Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hepatitis B Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Hepatitis B Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hepatitis B Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Hepatitis B Therapeutics Product
Table 64. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Hepatitis B Therapeutics Product
Table 69. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Novira Therapeutics Company Details
Table 72. Novira Therapeutics Business Overview
Table 73. Novira Therapeutics Hepatitis B Therapeutics Product
Table 74. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Novira Therapeutics Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Hepatitis B Therapeutics Product
Table 79. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Abivax Company Details
Table 82. Abivax Business Overview
Table 83. Abivax Hepatitis B Therapeutics Product
Table 84. Abivax Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Abivax Recent Development
Table 86. F. Hoffmann- La Roche Company Details
Table 87. F. Hoffmann- La Roche Business Overview
Table 88. F. Hoffmann- La Roche Hepatitis B Therapeutics Product
Table 89. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann- La Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Hepatitis B Therapeutics Product
Table 94. Novartis Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Hepatitis B Vaccine Features
Figure 3. Anti-viral Drugs Features
Figure 4. Global Hepatitis B Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Hepatitis B Therapeutics Report Years Considered
Figure 9. Global Hepatitis B Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hepatitis B Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hepatitis B Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Hepatitis B Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Hepatitis B Therapeutics Market Share by Players in 2020
Figure 14. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2020
Figure 16. Global Hepatitis B Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Hepatitis B Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hepatitis B Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Hepatitis B Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Hepatitis B Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hepatitis B Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Hepatitis B Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Hepatitis B Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hepatitis B Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hepatitis B Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hepatitis B Therapeutics Market Share by Region (2016-2027)
Figure 38. China Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hepatitis B Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Hepatitis B Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Hepatitis B Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis B Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hepatitis B Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hepatitis B Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 59. Novira Therapeutics Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 61. Abivax Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 62. F. Hoffmann- La Roche Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---